Schroder Investment Management Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.97M | Buy |
149,431
+32,824
| +28% | +$1.75M | 0.01% | 679 |
|
|
2025
Q1 | $4.98M | Buy |
116,607
+90,992
| +355% | +$3.89M | 0.01% | 756 |
|
|
2024
Q4 | $716K | Sell |
25,615
-158,817
| -86% | -$4.44M | ﹤0.01% | 1055 |
|
|
2024
Q3 | $5.21M | Sell |
184,432
-62,031
| -25% | -$1.75M | 0.01% | 780 |
|
|
2024
Q2 | $5.78M | Buy |
246,463
+75,507
| +44% | +$1.77M | 0.01% | 752 |
|
|
2024
Q1 | $4.32M | Buy |
+170,956
| New | +$4.32M | 0.01% | 807 |
|